Key Personnel Petra Pharma recently hired a Chief Medical Officer, Albert S. Yu, showcasing a focus on strengthening leadership and expertise in the field.
Strategic Collaborations Partnerships with Accelerator Life Science Partners, Evotec SE, and Schrödinger, Inc. highlight opportunities for expanding R&D capabilities and entering new markets.
Funding and Growth Having secured $48M in funding, Petra Pharma is poised for growth, enabling investment in product development, market expansion, and talent acquisition.
Advanced Drug Development Launching Phase 1b/2 studies and developing novel therapeutics like serabelisib demonstrate a commitment to cutting-edge drug development, presenting partnership and licensing opportunities.
Competitive Landscape Compared to similar companies like Schrödinger and Revolution Medicines, Petra Pharma's innovation in enzyme targets positions it as a key player in the biotechnology research sector with significant market potential.
966
$100M$1B
66
108$10M$50M
501$50M$100M
160$10M$50M
90$10M$50M
11
246
17$10MPetra Pharma Corporation uses 8 technology products and services including Google Analytics, WordPress, Twitter Emoji (Twemoji), and more. Explore Petra Pharma Corporation's tech stack below.
| Petra Pharma Corporation Email Formats | Percentage |
| FLast@petrapharmacorp.com | 38% |
| Last@petrapharmacorp.com | 12% |
| FLast@petrapharmacorp.com | 38% |
| Last@petrapharmacorp.com | 12% |
Biotechnology ResearchNew York, United States11-50 Employees
Petra Pharma is a drug development company focused on novel enzyme targets that play a central role in a variety of important cellular processes, including cell division, growth, trafficking, and signaling. Petra Pharma will develop novel small molecules for the treatment of cancer and metabolic diseases to target these cellular processes in order to therapeutically impact human health.
Company Overview
Media & News
Funding & FinancialsPetra Pharma Corporation has raised a total of $48M of funding over 1 rounds. Their latest funding round was raised on Nov 01, 2016 in the amount of $48Mas a Series A.
Funding & FinancialsPetra Pharma Corporation has raised a total of $48M of funding over 1 rounds. Their latest funding round was raised on Nov 01, 2016 in the amount of $48Mas a Series A.
1-888-653-2347 
support@leadiq.com